No study locations reported - 01 Sep `25Dexamethasone with light therapy for vitiligo

Dexamethasone with light therapy for vitiligo

Official title: Expression of CXCL11 & TEMRA in Serum of Vitiligo Patients Treated With Narrow-band UVB

Status: Opening soon

Description:

Assiut University plans to enroll about 40 participants. The study uses controlled ultraviolet light, sometimes with an immune-modulating medicine. UV light can stimulate surviving melanocytes and may help affected skin regain color. Possible effects include redness, itching, dryness, sunburn-like reactions, and with repeated exposure, premature skin aging or a higher skin-cancer risk. The study record does not list an age range. Recruitment has not started, and no locations are listed yet.

Start date: September 01, 2025

Completion date: September 30, 2026

Organizer: Assiut University

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT06946069

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Dexamethasone with light therapy for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Shall I take vitamin D for my vitiligo?

    Vitamin D plays a central role in the prevention of different inflammatory and chronic diseases. Consuming 1,000–4,000 IU (25–100 mcg) of vitamin D3 daily should be ideal for mo...

  • Will it spread?

    Vitiligo is famously unpredictable, but it doesn't move at random. By looking at thousands of cases, researchers have identified specific patterns of how the condition behaves. ...

  • How can I cure vitiligo?

    Right now, there is no universal "cure," but we have entered a new era of treatment. Today, managing vitiligo isn’t just about "hiding" it; it’s about sophisticated science that...